𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Designing antibodies for the inhibition of gastrin activity in tumoral cell lines

✍ Scribed by Rodrigo Barderas; Susana Shochat; Peter Timmerman; Martine J. Hollestelle; Jorge L. Martínez-Torrecuadrada; Jo W.M. Höppener; Danièle Altschuh; Rob Meloen; José Ignacio Casal

Publisher
John Wiley and Sons
Year
2008
Tongue
French
Weight
707 KB
Volume
122
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Gastrin and its derivatives are becoming important targets for immunotherapy of pancreatic, gastric and colorectal tumors. This study was conducted to design antibodies able to block gastrin binding to the gastrin/cholecystokinin‐2 (CCK‐2) receptor in order to delay tumor growth. The authors have used different gastrin molecules, combined with the diphtheria toxoid, to generate and select human single chain variable fragments (scFvs) as well as mouse monoclonal antibodies and scFvs against different regions of gastrin. There was a remarkable conservation in the antibody repertoire against gastrin, independently of the approach and the species. The germlines most frequently used in gastrin antibody formation were identified. Three different epitopes were identified in the gastrin molecule. The resulting mouse monoclonal antibodies and scFvs were analyzed for gastrin neutralization using Colo 320 WT cells, which overexpress the CCK‐2 receptor. The gastrin neutralizing activity assay showed that N‐terminal specific mouse monoclonal antibodies were more efficient to inhibit proliferation of Colo 320 WT cells than the anti‐C terminal antibodies. Moreover, the human antigastrin scFvs obtained in this study inhibited significantly the proliferation of Colo 320 tumoral cells. These findings should contribute to a more rational design of antibody‐based antigastrin therapies in cancer, including passive administration of human antibodies with blocking activity. © 2008 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Generation of a monoclonal antibody that
Generation of a monoclonal antibody that inhibits the procoagulant activity of various cancer cell lines
✍ Haruhiko Inufusa; Toshiyuki Adachi; Motoyuki Suzuki; Osamu Ando; Tsunetaka Ohta; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

## Background: Tumor procoagulant is one of the factors responsible for disseminated intravascular coagulation and metastasis. the authors found procoagulant activity in lk52 human squamous cell carcinoma cells, which they designated cancer cell-derived blood coagulating activity 1 (cca-1). a monoc

Activation of the retinoblastoma tumor s
Activation of the retinoblastoma tumor suppressor mediates cell cycle inhibition and cell death in specific cervical cancer cell lines
✍ Ryan J. Bourgo; Wesley A. Braden; Susanne I. Wells; Erik S. Knudsen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB

## Abstract High‐risk human papilloma virus (HPV) encodes two oncoproteins, E6 and E7, which are vital to viral replication and contribute to the development of cervical cancer. HPV16 E7 can target over 20 cellular proteins, but is best known for inactivating the retinoblastoma (RB) tumor suppresso

Tumor-suppressive activity of the growth
Tumor-suppressive activity of the growth arrest-specific gene GAS1 in human tumor cell lines
✍ Andreas Evdokiou; Prudence A. Cowled 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 261 KB 👁 2 views

The GAS1 gene product induces growth arrest through a p53-dependent mechanism. To investigate whether GAS1 is a tumor suppressor gene, we transfected GAS1-negative human tumor cells with GAS1 plasmids and analyzed growth characteristics of stable transfectants. When a constitutively expressing GAS1

Tumor-bound immunoglobulins. Evidence fo
Tumor-bound immunoglobulins. Evidence for the in vivo coating of tumor cells by potentially cytotoxic anti-tumor antibodies
✍ Maya Ran; Isaac P. Witz; George Klein 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 French ⚖ 679 KB

## Abstract The experiments described herein were designed to determine whether part of the Ig coat of tumor cells consists of specific anti‐tumor antibodies. It was demonstrated that the inoculation of polyoma virus‐induced sarcoma cells (SEYF‐a) into syngeneic A.B Y mice stimulates the production

The antitumor activity of an anti-CD54 a
The antitumor activity of an anti-CD54 antibody in SCID mice xenografted with human breast, prostate, non-small cell lung, and pancreatic tumor cell lines
✍ Kimberly J. Brooks; Elaine J. Coleman; Ellen S. Vitetta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 293 KB

## Abstract We have previously described the development and testing of a monoclonal anti‐human CD54 antibody (UV3) in SCID mice xenografted with human multiple myeloma, lymphoma, and melanoma cell lines. In all 3 cases, UV3 was highly effective at slowing the growth of tumors and/or prolonging sur